Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Wickel

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort StudyAmelie Bohn, Klemens Angstwurm, Christian G Bien, et al.
Journal of Neurology|February 22, 2024
Different pain phenotypes are associated with anti-Caspr2 autoantibodiesPatrik Greguletz, Maria Plötz, Carolin Baade-Büttner, et al.
JAMA Neurology|August 4, 2025
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseThomas Grüter, Carles Gaig, Yvette S Crijnen, et al.
Journal of Neurology|March 25, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2Joyce Christin Rittel, Dominica Hudasch, Kathrin Doppler, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2026
Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 PandemicJonathan Wickel, Ha-Yeun Chung, Franz Felix Konen, et al.
Journal of the Neurological Sciences|January 7, 2023
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy responseMarie Madlener, Christine Strippel, Franziska S Thaler, et al.
The Journal of Experimental Medicine|September 21, 2021
Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizuresJakob Kreye, Sukhvir K Wright, Adriana van Casteren, et al.
Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.
Journal of Neurology|December 21, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and visionMihaela Nicolescu, Vivien Häußler, Friedemann Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADVivien Häußler, Corinna Trebst, Daniel Engels, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Neurology(R) Neuroimmunology & Neuroinflammation|July 7, 2025
Comorbidities and Their Influence on Outcomes and Infectious Complications in Autoimmune Encephalitis: A Multicenter Cohort StudyAmelie Bohn, Klemens Angstwurm, Christian G Bien, et al.
Journal of Neurology|February 22, 2024
Different pain phenotypes are associated with anti-Caspr2 autoantibodiesPatrik Greguletz, Maria Plötz, Carolin Baade-Büttner, et al.
JAMA Neurology|August 4, 2025
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 DiseaseThomas Grüter, Carles Gaig, Yvette S Crijnen, et al.
Journal of Neurology|March 25, 2025
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2Joyce Christin Rittel, Dominica Hudasch, Kathrin Doppler, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 13, 2026
Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 PandemicJonathan Wickel, Ha-Yeun Chung, Franz Felix Konen, et al.
Journal of the Neurological Sciences|January 7, 2023
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy responseMarie Madlener, Christine Strippel, Franziska S Thaler, et al.
The Journal of Experimental Medicine|September 21, 2021
Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizuresJakob Kreye, Sukhvir K Wright, Adriana van Casteren, et al.
Neurology|July 2, 2026
Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort StudyDaniel Engels, Patrick Schindler, Joachim Havla, et al.
Journal of Neurology|December 21, 2024
Visual quality of life in NMOSD and MOGAD: profiles, dynamics and associations with ageing and visionMihaela Nicolescu, Vivien Häußler, Friedemann Paul, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 27, 2024
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGADVivien Häußler, Corinna Trebst, Daniel Engels, et al.
Pageof 5